欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号DE/H/3355/001
药品名称Dymista Nasenspray 137 Mikrogramm/50 Mikrogramm pro Sprühstoß Nasenspray, Suspension
活性成分
    • azelastine hydrochloride 0.1 g
    • fluticasone propionate 0.04 g
剂型Nasal spray, suspension
上市许可持有人Viatris Healthcare GmbH Lütticher Straße 5 53842 Troisdorf Germany
参考成员国 - 产品名称Germany (DE)
Dymista Nasenspray
互认成员国 - 产品名称
    • Latvia (LV)
    • Lithuania (LT)
      Dymista 137 mikrogramai/50 mikrogramų/dozėje nosies purškalas (suspensija)
    • Estonia (EE)
      DYMISTA
    • Hungary (HU)
      DYMISTA szuszpenziós orrspray
    • Bulgaria (BG)
      Dymista
    • Cyprus (CY)
      DYMISTA NASAL SPRAY
    • Czechia (CZ)
      Dymista Nosní sprej
    • Romania (RO)
      Dymista 137 micrograme/50 micrograme/doza spray nazal, suspensie
    • Slovakia (SK)
      Dymista nosová aerodisperzia
    • Slovenia (SI)
    • Malta (MT)
      Dymista Nasal Spray
    • Denmark (DK)
    • Luxembourg (LU)
    • Iceland (IS)
      Dymista 137 míkróg / 50 míkróg/skammt Nefúði, dreifa
    • Ireland (IE)
    • Liechtenstein (LI)
    • Austria (AT)
      Dymista 137 Mikrogramm/50 Mikrogramm pro Sprühstoß Nasenspray, Suspension
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Sweden (SE)
    • Norway (NO)
      Dymista
    • Finland (FI)
    • Poland (PL)
      Dymista
许可日期2013/01/24
最近更新日期2023/12/21
药物ATC编码
    • R01AD58 fluticasone, combinations
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Fixed combination Art 10b Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase